RELFOVETMAB
UNII MPR0ERS9LT

Substance Identification & Data

This profile provides standardized clinical and technical data for Relfovetmab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MPR0ERS9LT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2171034-70-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MPR0ERS9LT
CAS Registry Number
2171034-70-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RELFOVETMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174722
National Cancer Institute reference terminology for clinical and research data.
INN ID
11028
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Relfovetmab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RELFOVETMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(FELIS CATUS NERVE GROWTH FACTOR) (FELIS CATUS MONOCLONAL ZTS-00084768 .GAMMA.1-CHAIN), DISULFIDE WITH FELIS CATUS MONOCLONAL ZTS-00084768 .KAPPA.-CHAIN, DIMER
RELFOVETMAB [INN]

Technical Codes

ZTS-00084768

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus